What are the treatment options for managing melasma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Melasma

The most effective treatment for melasma is triple combination cream containing 4% hydroquinone, 0.05% tretinoin, and 0.01% fluocinolone acetonide, with 77-94% of patients achieving clear or almost clear skin. 1, 2

Diagnosis and Assessment

  • Determine skin phototype using Fitzpatrick scale
  • Identify depth of pigmentation (epidermal vs. dermal) using Wood's lamp examination
  • Classify melasma as epidermal, dermal, mixed, or indeterminate
  • Use Melasma Area and Severity Index (MASI) to measure extent and monitor treatment response

First-Line Treatment Options

Topical Therapies

  1. Triple Combination Cream

    • 4% hydroquinone + 0.05% tretinoin + 0.01% fluocinolone acetonide
    • Apply once daily for 8 weeks
    • Most effective first-line therapy with 77-94% clearance rates 2
    • Monitor for skin irritation and erythema
  2. Hydroquinone Monotherapy

    • 4% hydroquinone cream
    • Apply twice daily for 8-12 weeks
    • Effective for epidermal melasma
    • Caution: Do not use continuously beyond 6 months due to risk of ochronosis (blue-black discoloration) 1, 3
    • Test for skin sensitivity before full application 3
  3. Non-Hydroquinone Alternatives

    • Azelaic acid (15-20%)
    • Kojic acid
    • Formulations with tranexamic acid, vitamin C, arbutin, or niacinamide
    • Consider for patients with hydroquinone sensitivity or during maintenance phases

Second-Line Treatment Options

Oral Therapy

  • Tranexamic acid (250 mg twice daily)
  • For moderate to severe cases resistant to topical therapy
  • Caution: Screen for thromboembolic risk factors before initiating 1

Procedural Interventions

  1. Chemical Peels

    • Glycolic acid or salicylic acid peels
    • Consider after 8-12 weeks of unsuccessful topical therapy
    • 3-4 sessions spaced one month apart 1
    • Higher risk of post-inflammatory hyperpigmentation in darker skin types
  2. Advanced Procedures

    • Platelet-rich plasma (PRP) intradermal injections
    • Protocol: Once monthly for 3-5 sessions 1
    • Microneedling
    • Laser therapy (use with extreme caution in darker skin types)

Critical Adjunctive Measures

Sun Protection (Mandatory)

  • Broad-spectrum SPF 70 or higher sunscreen
  • Reapply every 2 hours when outdoors
  • Use protective clothing and wide-brimmed hats
  • Note: Inadequate sun protection is the most common reason for treatment failure 1

Treatment Monitoring

  • Evaluate response every 4-6 weeks using standardized photography
  • Assess using MASI score
  • Adjust treatment if no improvement after 8-12 weeks
  • Continue strict sun protection indefinitely, even after clearing

Treatment Algorithm

  1. Start with: Triple combination cream + strict sun protection
  2. If inadequate response after 8-12 weeks: Consider chemical peels or switch to alternative topicals
  3. For resistant cases: Add oral tranexamic acid or consider procedural interventions
  4. Maintenance phase: Intermittent hydroquinone use for recurrences, non-hydroquinone alternatives, and continued sun protection

Important Considerations

  • Hydroquinone has been associated with carcinogenesis concerns, though this remains debated 1
  • Aggressive treatments can worsen hyperpigmentation, especially in darker skin types
  • Treatment is typically long-term with potential for recurrence
  • Patient education about realistic expectations and importance of sun protection is crucial for successful outcomes 4, 5

References

Guideline

Platelet-Rich Plasma Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Melasma Treatment: An Evidence-Based Review.

American journal of clinical dermatology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.